Cargando…

Correction: EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells

Detalles Bibliográficos
Autores principales:	Takada, Honami, Imadome, Ken-Ichi, Shibayama, Haruna, Yoshimori, Mayumi, Wang, Ludan, Saitoh, Yasunori, Uota, Shin, Yamaoka, Shoji, Koyama, Takatoshi, Shimizu, Norio, Yamamoto, Kouhei, Fujiwara, Shigeyoshi, Miura, Osamu, Arai, Ayako
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538658/ https://www.ncbi.nlm.nih.gov/pubmed/28763513 http://dx.doi.org/10.1371/journal.pone.0182682

Ejemplares similares

EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells
por: Takada, Honami, et al.
Publicado: (2017)

P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases
por: Yoshimori, Mayumi, et al.
Publicado: (2015)

CD137 Expression Is Induced by Epstein-Barr Virus Infection through LMP1 in T or NK Cells and Mediates Survival Promoting Signals
por: Yoshimori, Mayumi, et al.
Publicado: (2014)

STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target
por: Onozawa, Erika, et al.
Publicado: (2018)

Interferon-γ Produced by EBV-Positive Neoplastic NK-Cells Induces Differentiation into Macrophages and Procoagulant Activity of Monocytes, Which Leads to HLH
por: Yoshimori, Mayumi, et al.
Publicado: (2021)

Novel Mouse Xenograft Models Reveal a Critical Role of CD4(+) T Cells in the Proliferation of EBV-Infected T and NK Cells
por: Imadome, Ken-Ichi, et al.
Publicado: (2011)

Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases
por: Kimura, Hiroshi, et al.
Publicado: (2019)

Modeling EBV infection and pathogenesis in new-generation humanized mice
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2015)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
por: Png, Yi Tian, et al.
Publicado: (2021)

EBV and the Pathogenesis of NK/T Cell Lymphoma
por: Montes-Mojarro, Ivonne A., et al.
Publicado: (2021)

EBV-associated NK and T-cell lymphoid neoplasms
por: Kimura, Hiroshi, et al.
Publicado: (2022)

Detection of EBV in reactive and neoplastic lymphoproliferations in adults—when and how?
por: Stuhlmann-Laeisz, Christiane, et al.
Publicado: (2014)

Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
por: Yang, Xi, et al.
Publicado: (2012)

EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood
por: Hong, Mineui, et al.
Publicado: (2013)

Challenges in Managing EBV-Associated T- and NK-Cell Lymphoproliferative Diseases
por: Sato, Yoshitaka
Publicado: (2018)

EBV & lymphoma
por: Caballero, Dolores
Publicado: (2019)

EBV and Lymphomagenesis
por: Sausen, Daniel G., et al.
Publicado: (2023)

New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders
por: Quintanilla-Martinez, Leticia, et al.
Publicado: (2022)

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
por: Zhang, Qiuting, et al.
Publicado: (2023)

The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein–Barr Virus Infection
por: Ohashi, Ayaka, et al.
Publicado: (2022)

Transcriptional profiling of Epstein–Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection
por: Zhang, Y, et al.
Publicado: (2006)

The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis
por: Salnikov, Mikhail Y., et al.
Publicado: (2023)

Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
por: Ramayanti, Octavia, et al.
Publicado: (2018)

The role of EBV-encoded miRNA in EBV-associated gastric cancer
por: Liu, Ting, et al.
Publicado: (2023)

EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts
por: Dojcinov, Stefan D., et al.
Publicado: (2018)

Clinical analysis of 42 cases of EBV-positive mature T/NK-cell neoplasms
por: Yang, Haiyan, et al.
Publicado: (2017)

Extranodal NK/T-cell lymphoma, nasal type without evidence of EBV infection
por: Wang, Wei, et al.
Publicado: (2020)

Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis
por: Saleem, Atif, et al.
Publicado: (2020)

Non-EBV-Related Aggressive NK-Cell Leukemia: An Oncohematological Great Imitator
por: Lepe-Zuniga, Jose L., et al.
Publicado: (2018)

Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma
por: Liu, Zhiwei, et al.
Publicado: (2021)

Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformation
por: Chen, Xia, et al.
Publicado: (2008)

Establishment of Epstein–Barr Virus (EBV) Latent Gene-Expressing T-Cell Lines with an Expression Vector Harboring EBV Nuclear Antigen 1
por: Kanno, Hiroyuki, et al.
Publicado: (2023)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

EBV Chronic Infections
por: Eligio, Pizzigallo, et al.
Publicado: (2010)

EBV and human cancer
por: Ko, Young-Hyeh
Publicado: (2015)

Antiviral Drugs for EBV
por: Pagano, Joseph S., et al.
Publicado: (2018)

Progress in EBV Vaccines
por: van Zyl, Dwain G., et al.
Publicado: (2019)

From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity
por: Kanduc, Darja, et al.
Publicado: (2020)

Unexpected Instability of Family of Repeats (FR), the Critical cis-Acting Sequence Required for EBV Latent Infection, in EBV-BAC Systems
por: Kanda, Teru, et al.
Publicado: (2011)

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)
por: Alberti, Andrea, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4l8k4f2ae84holcvekraf1ko8m